Overly broad Census categories force tens of millions of Americans to select “so...
A special European policy allows researchers at hospitals to make their own adva...
FTC, DOJ, and HHS are adding new officials to investigate price-gouging in healt...
It's time for @adamfeuerstein's list of Worst Biophama CEOs of the year.
CymaBay Therapeutics has filed a new drug application (NDA) with the FDA seeking...
The EMA CHMP recommended granting approval for Takeda’s Hyqvia for chronic infla...
The US FDA approved Astellas Pharma-Pfizer’s Padcev plus Merck’s (MSD) Keytruda ...
The latest $389m pledge follows an initial investment of $300m in 2017 that was ...
In this issue: Diabetes researchers oppose the regulation of islet transplantati...
Illumina aims to finalise the terms of this divestiture by the end of the second...
The Novo Nordisk Foundation has invested Dkr1.8bn in the initiative to develop v...
Following US and UK approvals, the EMA’s CHMP has recommended conditional approv...
Biocytogen Pharmaceuticals and Ona Therapeutics signed an antibody agreement to ...
“One of the reasons I retired was because I was expected to perform these annual...
What took so long for the World Health Organization to recognize the devastating...
Illumina, the leading maker of DNA sequencing machines, said it would divest Gra...
